William Grossman Insider Trades & Stock Holdings

Interim Chief Medical Officer · enGene Therapeutics Inc. · Latest filing Jun 16, 2026

William Grossman, Interim Chief Medical Officer at enGene Therapeutics Inc. has 1 Form 4 trade on file since Jun 16, 2026. Latest filing: acquired 231K shares of $ENGN on Jun 16, 2026.

Trades on file: 1
Open-market bought: $0
Open-market sold: $0
Net open-market: $0
Latest filing: Jun 16, 2026

All insider trades by William Grossman

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 16, 2026	$ENGN	Buy (Grant or award)	231K	$0	—			-2.3%	+9.7%		Interim Chief Medical Officer		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks William Grossman traded

$ENGN

Frequently asked questions

What was William Grossman's latest insider trade?

acquired 231K shares of $ENGN on Jun 16, 2026.

All insiders Insider cluster buys Top insider purchases Latest insider trade news

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text